1. Home
  2. XENE vs AHL Comparison

XENE vs AHL Comparison

Compare XENE & AHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • AHL
  • Stock Information
  • Founded
  • XENE 1996
  • AHL 2002
  • Country
  • XENE Canada
  • AHL Bermuda
  • Employees
  • XENE N/A
  • AHL N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • AHL Property-Casualty Insurers
  • Sector
  • XENE Health Care
  • AHL Finance
  • Exchange
  • XENE Nasdaq
  • AHL Nasdaq
  • Market Cap
  • XENE 2.4B
  • AHL 2.9B
  • IPO Year
  • XENE 2014
  • AHL 2025
  • Fundamental
  • Price
  • XENE $39.21
  • AHL $36.61
  • Analyst Decision
  • XENE Strong Buy
  • AHL Buy
  • Analyst Count
  • XENE 11
  • AHL 8
  • Target Price
  • XENE $52.73
  • AHL $39.44
  • AVG Volume (30 Days)
  • XENE 833.8K
  • AHL 1.1M
  • Earning Date
  • XENE 08-11-2025
  • AHL 08-07-2025
  • Dividend Yield
  • XENE N/A
  • AHL N/A
  • EPS Growth
  • XENE N/A
  • AHL N/A
  • EPS
  • XENE N/A
  • AHL 5.51
  • Revenue
  • XENE $7,500,000.00
  • AHL $3,179,300,000.00
  • Revenue This Year
  • XENE N/A
  • AHL N/A
  • Revenue Next Year
  • XENE $256.34
  • AHL $8.14
  • P/E Ratio
  • XENE N/A
  • AHL $6.65
  • Revenue Growth
  • XENE N/A
  • AHL 6.74
  • 52 Week Low
  • XENE $26.74
  • AHL $27.05
  • 52 Week High
  • XENE $46.00
  • AHL $36.84
  • Technical
  • Relative Strength Index (RSI)
  • XENE 67.80
  • AHL N/A
  • Support Level
  • XENE $38.13
  • AHL N/A
  • Resistance Level
  • XENE $39.84
  • AHL N/A
  • Average True Range (ATR)
  • XENE 0.99
  • AHL 0.00
  • MACD
  • XENE -0.09
  • AHL 0.00
  • Stochastic Oscillator
  • XENE 77.70
  • AHL 0.00

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About AHL Aspen Insurance Holdings Limited Class A Ordinary Shares

Aspen Insurance Holdings Ltd is a Bermudian insurance and reinsurance company. Its principal business is marketing and underwriting specialty insurance and reinsurance regularly. It comprises underwriting operations, which include risk-bearing insurance and reinsurance operations; Investing activities, which support underwriting operations; and ACM operations, which earn underwriting, management, and performance fees. It has two segments: Aspen Insurance and Aspen Reinsurance. Aspen Insurance consists of property and casualty insurance, marine, aviation, and energy insurance, and financial and professional lines insurance. Aspen Reinsurance comprises property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance.

Share on Social Networks: